Cameroon's MDR-TB treatment programme jeopardised by cross-border migration

European Respiratory Journal

Volumn 47, Issue 2, 2016, Pages 684-686

  Noeske, Jürgen ^a   Foe, Jean Louis Abena ^a   Kuaban, Christopher ^b,c  

^a National Tuberculosis Control Programme   (Cameroon)

^b UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^c UNIVERSITY OF BAMENDA   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; OFLOXACIN; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

CAMEROON; COMBINATION CHEMOTHERAPY; CROSS BORDER MIGRATION; DRUG EXPOSURE; DRUG TOLERABILITY; FUNDING; HEALTH CARE UTILIZATION; HUMAN; INTERNATIONAL COOPERATION; LETTER; MIGRATION; MULTIDRUG RESISTANT TUBERCULOSIS; OUTCOME ASSESSMENT; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT DURATION; TUBERCULOSIS CONTROL; COMMUNICABLE DISEASE CONTROL; DEVELOPED COUNTRY; FEMALE; HEALTH; MALE; ORGANIZATION AND MANAGEMENT; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; COMMUNICABLE DISEASE CONTROL; DEVELOPED COUNTRIES; FEMALE; GLOBAL HEALTH; HUMANS; MALE; TUBERCULOSIS;

EID: 84958069035     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.01324-2015     Document Type: Letter

References (10)

1. Lönnroth K, Migliori GB, Abubakar I, et al. Towards tuberculosis elimination: an action framework for low-incidence countries. Eur Respir J 2015; 45: 928-952.
2. Van Deun A, Salim MA, Das AP, et al. Results of a standardized regimen for multidrug-resistant tuberculosis in Bangladesh. Int J Tuberc Lung Dis 2004; 8: 560-567.
3. Van Deun A, Maug AK, Salim MA, et al. Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis. Am J Respir Crit Care Med 2010; 182: 684-692.
4. Kuaban C, Noeske J, Rieder H, et al. High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon. Int J Tuberc Lung Dis 2015; 19: 517-524.
5. Falzon D, Jaramillo E, Schünemann HJ, et al. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J 2011; 38: 516-528.
6. Chiang C-Y, Van Deun A, Enarson DA. A poor drug-resistant tuberculosis programme is worse than no programme: time for a change. Int J Tuberc Lung Dis 2013; 17: 714-718.
7. Falzon D, Gandhi N, Migliori GB, et al. Resistance to fluoroquinolones and second-line injectable drugs: impact on MDR-TB outcomes. Eur Respir J 2013; 42: 156-168.
8. D'Ambrosio L, Dara M, Tadolini M, et al. Tuberculosis elimination: theory and practice in Europe. Eur Respir J 2014; 43: 1410-1420.
9. Migliori GB, Lienhardt C, Weyer K, et al. Outcome of an ERS multisectoral consultation. Eur Respir J 2014; 44: 1412-1417.
10. Stop TB Partnership. Stop TB Partnership calls for Urgent Action on Antimicrobial Resistance at the United Nations in New York.. Available from http://tbonline.info/posts/2015/6/21/stop-tb-partnership-calls-urgent-action-antimicrob/ Date last updated: June 21, 2015. Date last accessed: Oct 30, 2015.